Costing Practices in pharmaceutic Companies of Bangladesh |1. Introduction | | 1.1 Background Pharmaceutical industriousness has grown in Bangladesh in the last dickens decades at a considerable rate. The sector consistently creates lineage opportunities for extremely qualified people. Many established entrepreneurs of today started with pharmaceutic companies in the country. Pharmaceutical companies are both directly or indirectly contributing largely towards raising the standard of healthcare finished enabling local healthcare personnel to pass water advance to newer products and also to latest medicate information. Following the demigod (Control) law of 1982, some of the local pharmaceutical companies improved govern and feeling of their products considerably. The topic companies account for m ore than 65% of the pharmaceutical avocation in Bangladesh. However, among the top 20 companies of Bangladesh 6 are multinationals. more or less alone the life saving imported products and new advanced molecules are channeled into and marketed in Bangladesh with these companies.
Multinational and large national companies generally follow true good manufacturing practices (cGMP) including rigorous fiber control of their products. In 2000, thither were 210 licensed allopathic medicine-manufacturing units in the country, out of which only 173 were on active production; others were either closed down on their own or hang by the licensing authority for! doses receivable to non compliance to GMP or drug laws. They manufactured about 5,600 brands of medicines in different dosage forms. in that respect were, however, 1,495 wholesale drug license holders and about 37,700 retail drug license holders in Bangladesh. One of the major positive impacts of Drug (Control) Ordinance is the quick development of local manufacturing capability. Almost all types of possible dosage forms include tablets,...If you want to get a full essay, rig it on our website: OrderCustomPaper.com
If you want to get a full essay, visit our page: write my paper
No comments:
Post a Comment